Positron Opens Pharmaceutical Facility in Indiana
08/10/2010
"While the company's plan is to focus on small batch, radioactive PET products, the facility will also be utilized to support current and future Positron equipment, as well as, expand into new markets," said John Zehner, Positron COO.
The approximately 10,000-square-foot facility has room for the company to expand, and includes a clean room and laboratory to produce pharmaceuticals for industrial and medical applications. All products made at the Indiana facility will meet or exceed Food and Drug Administration (FDA) requirements.
Most Read
-
-
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
-
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
-
What Should High-Growth Companies Look for in a Community?
Q4 2019
-
Front Line: Trend Toward Microfactories Continues
Q4 2019
-
A Changing Food Manufacturing Industry
2017 Food Processing
-
33rd Annual Corporate Survey & the 15th Annual Consultants Survey
Q1 2019